|
MCM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.41320000035527E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.48689999990692E-07 |
| Normal-vs-Stage2 |
6.716200E-02 |
| Normal-vs-Stage3 |
3.64980000000514E-06 |
| Normal-vs-Stage4 |
2.008500E-04 |
| Stage1-vs-Stage2 |
1.795780E-01 |
| Stage1-vs-Stage3 |
6.401800E-01 |
| Stage1-vs-Stage4 |
8.997400E-01 |
| Stage2-vs-Stage3 |
1.221440E-01 |
| Stage2-vs-Stage4 |
2.171200E-01 |
| Stage3-vs-Stage4 |
8.240200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.8664000051879E-08 |
| Normal-vs-AfricanAmerican |
2.376000E-03 |
| Normal-vs-Asian |
6.22129999999776E-05 |
| Caucasian-vs-AfricanAmerican |
2.012400E-01 |
| Caucasian-vs-Asian |
6.062800E-01 |
| AfricanAmerican-vs-Asian |
4.526000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.771540E-04 |
| Normal-vs-Female |
1.11049999973467E-07 |
| Male-vs-Female |
4.452800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.12280000022602E-07 |
| Normal-vs-Age(41-60Yrs) |
2.58060000002391E-06 |
| Normal-vs-Age(61-80Yrs) |
8.602100E-04 |
| Normal-vs-Age(81-100Yrs) |
4.169600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.461600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.123400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.175000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.264200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.143800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.496400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.067000E-01 |
| Classical-VS-Follicular |
1.06999997750989E-09 |
| Classical-VS-Other |
2.394800E-01 |
| Classical-VS-Normal |
2.88320034513845E-10 |
| Tall-VS-Follicular |
1.08990000002862E-06 |
| Tall-VS-Other |
5.618300E-02 |
| Tall-VS-Normal |
1.62490000343851E-08 |
| Follicular-VS-Other |
4.109400E-01 |
| Follicular-VS-Normal |
9.171400E-01 |
| Other-VS-Normal |
4.796400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.99219999999745E-05 |
| Normal-vs-N1 |
1.721580E-02 |
| N0-vs-N1 |
9.649200E-01 |
|
|
